Alzamend Neuro is trading at $1.27 (-5.22%) in pre-market after a quiet session with no company-specific catalyst found in available news.
- Broader markets are slightly firmer, with the S&P 500, Nasdaq Composite, and Dow all up pre-market, suggesting the move is not driven by index weakness.
- The price action likely reflects light early trading volume in a thinly traded name rather than fundamental news.